Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Clinical trial: Some sarcoma patients improve with T cell immunotherapy medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
According to a study led by Washington University School of Medicine in St. Louis, a new T cell immunotherapy in which the patients’ own T cells are genetically modified to attack and kill cancer cells is effective in treating some patients with two types of sarcoma, rare cancers of the body’s soft tissues.